From Sweta Jaiswal
: President Trump's latest move to raise the tariffs to 25% from 10% on $200 billion of Chinese goods might have 'trumped' hopes of many investors waiting for a truce between the two largest economies. However, amid this political conundrum, the biotech
industry has kept its promise for solid returns so far. The rally in some major biotechnology indexes reflects the same. In this context, the NASDAQ Biotechnology Index
has returned 11.5% year to date.